Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9.
Lancet Neurol. 2021.
PMID: 34146511
Clinical Trial.
Establishing Stroke Services in the Republic of Georgia.
Katsarava Z, Akhvlediani T, Janelidze T, Gudadze T, Todua M, Akhvlediani K, Khinikadze M, Egutidze G, Margania T, Tsiskaridze A.
Katsarava Z, et al. Among authors: margania t.
Eur Neurol. 2022;85(1):56-64. doi: 10.1159/000518845. Epub 2021 Sep 20.
Eur Neurol. 2022.
PMID: 34569481
Item in Clipboard
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team.
Bril V, et al.
Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7.
Lancet Neurol. 2023.
PMID: 37059507
Clinical Trial.
Item in Clipboard
Cite
Cite